149 related articles for article (PubMed ID: 17989512)
1. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats.
Desai RI; Neumeyer JL; Bergman J; Paronis CA
Behav Pharmacol; 2007 Dec; 18(8):745-54. PubMed ID: 17989512
[TBL] [Abstract][Full Text] [Related]
2. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
Jutkiewicz EM; Bergman J
J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
Desai RI; Neumeyer JL; Paronis CA; Nguyen P; Bergman J
Eur J Pharmacol; 2007 Mar; 558(1-3):98-106. PubMed ID: 17207791
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys.
Kleven MS; Koek W
J Pharmacol Exp Ther; 1996 Dec; 279(3):1211-9. PubMed ID: 8968343
[TBL] [Abstract][Full Text] [Related]
5. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
[TBL] [Abstract][Full Text] [Related]
7. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
[TBL] [Abstract][Full Text] [Related]
8. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Desai RI; Terry P; Katz JL
Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine.
Chocyk A; Czyrak A; Wedzony K
J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex.
Charbit AR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):752-63. PubMed ID: 19657051
[TBL] [Abstract][Full Text] [Related]
12. Transient dopamine synthesis modulation in prefrontal cortex: in vitro studies.
Dumont NL; Andersen SL; Thompson AP; Teicher MH
Brain Res Dev Brain Res; 2004 Jun; 150(2):163-6. PubMed ID: 15158079
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
[TBL] [Abstract][Full Text] [Related]
14. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
[TBL] [Abstract][Full Text] [Related]
15. Characterization of dopamine D1 and D2 receptor function in socially housed cynomolgus monkeys self-administering cocaine.
Czoty PW; Morgan D; Shannon EE; Gage HD; Nader MA
Psychopharmacology (Berl); 2004 Jul; 174(3):381-8. PubMed ID: 14767632
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.
Makihara Y; Okuda Y; Kawada C; Matsumoto M; Waddington JL; Koshikawa N; Tomiyama K
Neurosci Lett; 2007 Mar; 415(1):6-10. PubMed ID: 17234342
[TBL] [Abstract][Full Text] [Related]
17. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm.
Zhang ZJ; Jiang XL; Zhang SE; Hough CJ; Li H; Chen JG; Zhen XC
Neurosci Lett; 2005 Jul 1-8; 382(1-2):134-8. PubMed ID: 15911136
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the discriminative stimulus properties of the dopamine D1 agonist, SKF 81297.
Reavill C; B Bond ; Overend P; Hunter AJ
Behav Pharmacol; 1993 Apr; 4(2):135-146. PubMed ID: 11224180
[TBL] [Abstract][Full Text] [Related]
19. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
McLean SL; Idris NF; Woolley ML; Neill JC
Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 receptor modulation of set shifting: the role of stress exposure.
Nikiforuk A
Behav Pharmacol; 2012 Aug; 23(4):434-8. PubMed ID: 22743605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
